HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
NYSE:HIMS • US4330001060
14.52 USD
-1.08 (-6.92%)
At close: Feb 27, 2026
14.55 USD
+0.03 (+0.21%)
After Hours: 2/27/2026, 8:08:36 PM
HIMS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of HIMS while its profitability can be described as average. HIMS has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- HIMS had positive earnings in the past year.
- In the past year HIMS had a positive cash flow from operations.
- In multiple years HIMS reported negative net income over the last 5 years.
- The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
- HIMS's Return On Assets of 5.99% is amongst the best of the industry. HIMS outperforms 82.18% of its industry peers.
- Looking at the Return On Equity, with a value of 23.03%, HIMS belongs to the top of the industry, outperforming 90.10% of the companies in the same industry.
- With a decent Return On Invested Capital value of 5.84%, HIMS is doing good in the industry, outperforming 62.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of HIMS (6.05%) is better than 82.18% of its industry peers.
- Looking at the Operating Margin, with a value of 5.96%, HIMS is in the better half of the industry, outperforming 66.34% of the companies in the same industry.
- The Gross Margin of HIMS (75.01%) is better than 90.10% of its industry peers.
- In the last couple of years the Gross Margin of HIMS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HIMS is destroying value.
- Compared to 1 year ago, HIMS has more shares outstanding
- HIMS has more shares outstanding than it did 5 years ago.
- HIMS has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.60 indicates that HIMS is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a Altman-Z score value of 2.60, HIMS perfoms like the industry average, outperforming 57.43% of the companies in the same industry.
- HIMS has a debt to FCF ratio of 8.13. This is a slightly negative value and a sign of low solvency as HIMS would need 8.13 years to pay back of all of its debts.
- HIMS has a Debt to FCF ratio (8.13) which is in line with its industry peers.
- A Debt/Equity ratio of 1.67 is on the high side and indicates that HIMS has dependencies on debt financing.
- HIMS has a Debt to Equity ratio of 1.67. This is in the lower half of the industry: HIMS underperforms 69.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 2.6 |
ROIC/WACC0.68
WACC8.61%
2.3 Liquidity
- HIMS has a Current Ratio of 1.88. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of HIMS (1.88) is better than 78.22% of its industry peers.
- HIMS has a Quick Ratio of 1.64. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
- HIMS has a Quick ratio of 1.64. This is in the better half of the industry: HIMS outperforms 68.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
- HIMS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.41%.
EPS 1Y (TTM)-7.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.41%
3.2 Future
- HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.33% yearly.
- HIMS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.27% yearly.
EPS Next Y16.28%
EPS Next 2Y26.07%
EPS Next 3Y68.86%
EPS Next 5Y51.33%
Revenue Next Year16.69%
Revenue Next 2Y17.68%
Revenue Next 3Y13.77%
Revenue Next 5Y12.27%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 29.04, the valuation of HIMS can be described as expensive.
- HIMS's Price/Earnings is on the same level as the industry average.
- HIMS's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.10.
- A Price/Forward Earnings ratio of 24.97 indicates a rather expensive valuation of HIMS.
- The rest of the industry has a similar Price/Forward Earnings ratio as HIMS.
- HIMS's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.06.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.04 | ||
| Fwd PE | 24.97 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HIMS is on the same level as its industry peers.
- HIMS's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.66 | ||
| EV/EBITDA | 20.71 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- HIMS has a very decent profitability rating, which may justify a higher PE ratio.
- HIMS's earnings are expected to grow with 68.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.78
PEG (5Y)N/A
EPS Next 2Y26.07%
EPS Next 3Y68.86%
5. Dividend
5.1 Amount
- HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
14.52
-1.08 (-6.92%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-23 2026-02-23/amc
Earnings (Next)05-04 2026-05-04
Inst Owners94.2%
Inst Owner Change-9.84%
Ins Owners5.93%
Ins Owner Change-1.34%
Market Cap3.31B
Revenue(TTM)N/A
Net Income(TTM)133.79M
Analysts67.27
Price Target30 (106.61%)
Short Float %37.45%
Short Ratio3.62
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-2.29%
PT rev (3m)-11.57%
EPS NQ rev (1m)15.33%
EPS NQ rev (3m)-32.54%
EPS NY rev (1m)0.73%
EPS NY rev (3m)-20.78%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.04 | ||
| Fwd PE | 24.97 | ||
| P/S | 1.5 | ||
| P/FCF | 27.66 | ||
| P/OCF | 10.17 | ||
| P/B | 5.69 | ||
| P/tB | 26.07 | ||
| EV/EBITDA | 20.71 |
EPS(TTM)0.5
EY3.44%
EPS(NY)0.58
Fwd EY4%
FCF(TTM)0.52
FCFY3.61%
OCF(TTM)1.43
OCFY9.83%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)1.78
PEG (5Y)N/A
Graham Number5.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 2.6 |
F-Score3
WACC8.61%
ROIC/WACC0.68
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.36%
EPS Next Y16.28%
EPS Next 2Y26.07%
EPS Next 3Y68.86%
EPS Next 5Y51.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.41%
Revenue Next Year16.69%
Revenue Next 2Y17.68%
Revenue Next 3Y13.77%
Revenue Next 5Y12.27%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year350.34%
EBIT Next 3Y88.26%
EBIT Next 5Y57.83%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to HIMS.
What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a valuation rating of 4 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Fairly Valued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the financial health of HIMS & HERS HEALTH INC (HIMS) stock?
The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 3 / 10.